192 related articles for article (PubMed ID: 36899895)
21. Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures.
Ramachandran GK; Yeow CH
Biol Res; 2017 Mar; 50(1):12. PubMed ID: 28302167
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells.
Ramos CJ; Gutierrez DA; Aranda AS; Koshlaychuk MA; Carrillo DA; Medrano R; McBride TD; U A; Medina SM; Lombardo MC; Lucena SE; Sanchez EE; Soto JG
Toxicon; 2016 Aug; 118():36-42. PubMed ID: 27105671
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein.
Prasad R; Katiyar SK
Oncotarget; 2014 Nov; 5(21):10636-49. PubMed ID: 25361006
[TBL] [Abstract][Full Text] [Related]
24. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
Paccosi S; Cecchi M; Silvano A; Fabbri S; Parenti A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3155-3163. PubMed ID: 32776284
[TBL] [Abstract][Full Text] [Related]
25. Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A.
Mazzio EA; Soliman KFA
Cancer Genomics Proteomics; 2018; 15(5):349-364. PubMed ID: 30194076
[TBL] [Abstract][Full Text] [Related]
26. [miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
Li J; Zhao R; Fang R; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1360-1365. PubMed ID: 30514686
[TBL] [Abstract][Full Text] [Related]
27. X-ray microtomography as a new approach for imaging and analysis of tumor spheroids.
Karimi H; Leszczyński B; Kołodziej T; Kubicz E; Przybyło M; Stępień E
Micron; 2020 Oct; 137():102917. PubMed ID: 32693343
[TBL] [Abstract][Full Text] [Related]
28. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness.
Rossi S; Cordella M; Tabolacci C; Nassa G; D'Arcangelo D; Senatore C; Pagnotto P; Magliozzi R; Salvati A; Weisz A; Facchiano A; Facchiano F
J Exp Clin Cancer Res; 2018 Dec; 37(1):326. PubMed ID: 30591049
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Epithelial-Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel.
Nakamura H; Watanabe M; Takada K; Sato T; Hikage F; Umetsu A; Muramatsu J; Furuhashi M; Ohguro H
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790973
[TBL] [Abstract][Full Text] [Related]
31. Preparation, Drug Treatment, and Immunohistological Analysis of Tri-Culture Spheroid 3D Melanoma-Like Models.
Schäfer MEA; Klicks J; Hafner M; Rudolf R
Methods Mol Biol; 2021; 2265():173-183. PubMed ID: 33704714
[TBL] [Abstract][Full Text] [Related]
32. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
[TBL] [Abstract][Full Text] [Related]
33. Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence.
Allavena G; Del Bello B; Tini P; Volpi N; Valacchi G; Miracco C; Pirtoli L; Maellaro E
J Cell Physiol; 2019 Jul; 234(7):11708-11721. PubMed ID: 30488547
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis in melanoma cell lines by p53 and its related proteins.
Yamashita T; Tokino T; Tonoki H; Moriuchi T; Jin HY; Omori F; Jimbow K
J Invest Dermatol; 2001 Oct; 117(4):914-9. PubMed ID: 11676832
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.
Yamazaki H; Chijiwa T; Inoue Y; Abe Y; Suemizu H; Kawai K; Wakui M; Furukawa D; Mukai M; Kuwao S; Saegusa M; Nakamura M
Exp Ther Med; 2012 May; 3(5):793-796. PubMed ID: 22969970
[TBL] [Abstract][Full Text] [Related]
36. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
38. 22β-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling.
Aranha ESP; Portilho AJS; Bentes de Sousa L; da Silva EL; Mesquita FP; Rocha WC; Araújo da Silva FM; Lima ES; Alves APNN; Koolen HHF; Montenegro RC; Vasconcellos MC
J Ethnopharmacol; 2021 Mar; 267():113605. PubMed ID: 33232779
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture.
Aughton K; Shahidipour H; Djirackor L; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2020 Jun; 9(7):39. PubMed ID: 32832244
[TBL] [Abstract][Full Text] [Related]
40. Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Dermatoendocrinol; 2009 Jul; 1(4):232-8. PubMed ID: 20592797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
